Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to the body’s inability to produce ...
Do you have questions about the biggest topics and trends from around the world ... When blood sugar levels rise, the ...
A Georgia father of four is recovering after suffering major burns over a large part of his body last week. But Caliph ...